1. Home
  2. HNRG vs RGNX Comparison

HNRG vs RGNX Comparison

Compare HNRG & RGNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

HNRG

Hallador Energy Company

SELL

Current Price

$10.38

Market Cap

552.0M

Sector

Energy

ML Signal

SELL

Logo REGENXBIO Inc.

RGNX

REGENXBIO Inc.

SELL

Current Price

$7.53

Market Cap

487.2M

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
HNRG
RGNX
Founded
1949
2008
Country
United States
United States
Employees
N/A
N/A
Industry
Coal Mining
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
552.0M
487.2M
IPO Year
1995
2015

Fundamental Metrics

Financial Performance
Metric
HNRG
RGNX
Price
$10.38
$7.53
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
11
Target Price
★ $28.00
$21.40
AVG Volume (30 Days)
1.1M
★ 1.2M
Earning Date
11-09-2026
11-05-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 116.78
18.08
EPS
★ N/A
N/A
Revenue
★ $469,466,000.00
$10,393,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$24.01
P/E Ratio
★ N/A
N/A
Revenue Growth
16.09
★ 126.48
52 Week Low
$8.85
$5.46
52 Week High
$23.44
$16.19

Technical Indicators

Market Signals
Indicator
HNRG
RGNX
Relative Strength Index (RSI) 40.44 49.11
Support Level $8.85 $6.79
Resistance Level $12.11 $8.31
Average True Range (ATR) 0.72 0.60
MACD 0.13 0.08
Stochastic Oscillator 47.30 43.79

Price Performance

Historical Comparison
HNRG
RGNX

About HNRG Hallador Energy Company

Hallador Energy Co is a vertically integrated, independent power producer (IPP) and fuel company with operations in Indiana. The Company operates across multiple stages of the energy value chain, from accredited capacity and energy to coal. The Company's electric operations are located within the Midcontinent Independent System Operator's (MISO) footprint. The company's business is organized based on the services and products it provide in two segments: (i) Electric Operations and (ii) Coal Operations.

About RGNX REGENXBIO Inc.

Regenxbio Inc is a clinical-stage biotechnology company focused on the development of gene therapy treatments. Its product candidates are designed to deliver genes to cells to address genetic defects or enable the production of therapeutic proteins. The company is developing a pipeline of investigational gene therapy treatments using its NAV Technology Platform based on adeno-associated virus (AAV) vectors. Its internal research and development programs are focused on therapies for retinal, neuromuscular, and neurodegenerative diseases.

Share on Social Networks: